Laryngeal papillomavirus infection during clinical remission.
about
Latent infection induced with cottontail rabbit papillomavirus. A model for human papillomavirus latencyDiagnostic and therapeutic pitfalls in benign vocal fold diseases.Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis.Characterization of human papillomavirus in airway papillomas by histologic and biochemical analysis.Novel treatments for recurrent respiratory papillomatosis.Detection of human papillomavirus infection in diseased and nondiseased sites of the respiratory tract in recurrent respiratory papillomatosis patients by DNA hybridization.Polymerase chain reaction identification of human papillomavirus DNA in CO2 laser plume from recurrent respiratory papillomatosis.Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression.Changes in HPV infection in patients with anogenital warts and their partnersAltered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease.Treatment of nasopharyngeal papillomatosis with coblation: a case series.HspE7 treatment of pediatric recurrent respiratory papillomatosis: final results of an open-label trial.Management of common voice problems: Committee report.Pharmacotherapy of recurrent respiratory papillomatosis.Clinical practice guideline: hoarseness (dysphonia).Genital human papillomavirus infectionTreatment of respiratory papillomatosis with adenine arabinoside.The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells.Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.Human papilloma virus infections.The biology of papillomavirus latency.Human papillomaviruses: are we ready to type?Papova viruses and recurrent laryngeal papillomatosis.Tissue site-specific enhancer function of the upstream regulatory region of human papillomavirus type 11 in cultured keratinocytes.Transcriptional regulatory elements in the noncoding region of human papillomavirus type 6.Management of adult recurrent respiratory papillomatosis with oral acyclovir following micro laryngeal surgery: a case series.The natural history of human papillomavirus infections of the mucosal epithelia.Epidemiology of recurrent respiratory papillomatosis.Nucleic acid probes in clinical microbiology.Analysis of prevalence of human papillomavirus in laryngeal carcinomas. Study of 40 cases using polymerase chain reaction and consensus primers.Squamous cell carcinoma of the respiratory tract following laryngeal papillomatosis.Hypnotherapeutic intervention for voice disorders related to recurring juvenile laryngeal papillomatosis.Sites of predilection in recurrent respiratory papillomatosis.Prevalence of human papillomavirus in squamous cell carcinoma of the head and neck determined by polymerase chain reaction and Southern blot hybridization: proposal for optimized diagnostic requirements.Human papillomavirus type 11 DNA in squamous cell carcinomas and pre-existing multiple laryngeal papillomas.Detection of Human Papillomavirus in Routinely Processed Biopsy Specimens from Laryngeal Papillomas: Evaluation of Reproducibility of Polymerase Chain Reaction and DNA in Situ Hybridization Procedures
P2860
Q24676486-6EE4E3DB-36D4-4FCD-9E50-8F5AB5B50B1AQ30444645-9DAAD6C6-D645-46CF-A091-11842554EA64Q30450185-61AD3375-E70C-4956-BCED-B4AF3CEDF934Q30819811-991A0E89-5C06-4F2C-9349-BA1B1E112B8EQ31099594-A3043BE3-95DC-4347-B0D9-0B66354E62DFQ31160496-B10E19FB-4C14-4E37-8C06-69DDE882D53EQ33335869-FEC3F4D2-25E1-43B4-AA68-910E6B94941CQ33873015-2E6375FD-B6CD-4550-8266-4FA987731A23Q33934630-87E6576A-437E-4931-B523-6FB0364C57AEQ33998134-BF20A569-D72A-44BD-8EF7-8B2B6B4E62F7Q34144400-9F5A2BD6-9741-48F2-94F2-AF62B21A5310Q34461719-6F17D701-E820-4A94-AD86-510F0CDC0E67Q34629263-20308908-F98C-470B-BAB3-459C75A5C8A4Q34768490-D4748A40-9DB4-4B08-A847-0BA53449C12BQ35001102-4018914B-6E4E-40AD-98AB-7D34B99B4910Q35114105-A280251B-AFA6-4EAC-9B8B-9B9DBC4A4438Q35601857-761DEEC3-B95D-442A-95EB-47D2C8E94F89Q35857475-585586D4-3A77-4627-90A5-01D60EE3A1A4Q36188323-F0F23216-CD2D-42D6-8B18-D8C9CC000673Q36520200-97BF06F6-F800-4010-9970-612215A488C5Q36540467-84981141-2921-4DAD-90A3-74276F5A3AC5Q36635041-0638121D-A978-46BD-A73F-CD800C962DD1Q36687304-B51F7583-58A1-411D-A272-8D327AA3EB2BQ36781076-E9D76359-83CF-447C-B1B0-CC03D0CBD9D5Q36874193-932FCA2D-5EAD-4CBC-9C16-90AA418FF397Q37569673-CEA4AD80-65EC-41A1-A4D8-EFB9135A7C1EQ37765656-E93D7758-1548-408C-9571-90C7C94D0144Q37765657-FFE40D6D-E3CD-4F54-B5F6-E0A43C835153Q39662489-511B04C8-B5DD-4E49-AAFA-71AA79717417Q40853136-C1E31B91-C746-40A3-85A1-5552DBFE8497Q44957873-93A18E74-1E3D-498A-AD7B-E6DB637D5946Q48843209-11A9D47E-2B38-468E-914B-EFF85F4AB93CQ51140793-E241B870-6B52-4662-A0B8-A95DC38FBE4FQ53436275-ED544958-B0B7-43C3-80C1-C84E343790CAQ53518491-AF0CD6EC-7F24-49AB-B8C6-3C046161AB7CQ58266048-86A64968-7C1E-487C-B77A-0A5F34FCE304
P2860
Laryngeal papillomavirus infection during clinical remission.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh-hant
name
Laryngeal papillomavirus infection during clinical remission.
@en
Laryngeal papillomavirus infection during clinical remission.
@nl
type
label
Laryngeal papillomavirus infection during clinical remission.
@en
Laryngeal papillomavirus infection during clinical remission.
@nl
prefLabel
Laryngeal papillomavirus infection during clinical remission.
@en
Laryngeal papillomavirus infection during clinical remission.
@nl
P2093
P1476
Laryngeal papillomavirus infection during clinical remission.
@en
P2093
Abramson AL
Schneider PS
P304
P356
10.1056/NEJM198305263082104
P407
P577
1983-05-01T00:00:00Z